Studying New Treatments for Medulloblastoma
Treatments studied
Part of Cancer clinical trials.
This trial is studying the genetic details of medulloblastoma tumors in children to find new, targeted treatments. If your child had surgery for medulloblastoma at our pediatric center, their tumor tissue may help us learn more.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You or your child have been diagnosed with medulloblastoma, a type of brain tumor.
- The tumor was removed with surgery at a children's hospital.
- The surgery took place while the patient was still a child (pediatric age).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at the DNA of medulloblastoma (a common childhood brain tumor) to create a better way of classifying the tumor's risk. By understanding the tumor's specific genetic features, doctors hope to tailor treatment more accurately and improve outcomes for children.
This study tests a personalized treatment plan for children and young adults whose medulloblastoma or ependymoma has come back. It aims to guide doctors using new tissue from surgery or biopsy after earlier treatments are fully finished.
This trial tests a combination of chemotherapy drugs (topotecan given into the spine plus maintenance chemo) for children under 6 with high-risk embryonal brain tumors. The goal is to see if this approach can improve outcomes after initial treatment.
This trial tests whether adding a thyroid hormone (liothyronine) to a standard chemotherapy combination (bevacizumab, irinotecan, temozolomide) can help children and young adults with medulloblastoma that has come back after initial treatment.
This Phase 2 trial tests how doctors choose treatment for infants and young children with newly diagnosed medulloblastoma, based on MRI/CSF staging and lab testing of the tumor. It may help by matching therapy intensity to the child’s specific risk level and tumor type.
This trial compares two standard treatment plans for young children with a specific type of medulloblastoma (a brain tumor). It looks at how each treatment affects thinking and learning over time, to see which one helps children do better in the long run.
Hear when a new Medulloblastoma, Childhood trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.